SYNGENE INTERNATIONAL LTD UNIT VII

SYNGENE INTERNATIONAL LTD UNIT VII

Company Type: Factory / Research and Manufacturing Facility

Company Introduction:

Syngene International Ltd Unit VII is an operational site of Syngene International Ltd, a leading integrated research, development, and manufacturing organization. Syngene provides comprehensive discovery and development services to clients in the pharmaceutical, biotechnology, nutrition, animal health, and consumer goods sectors. Unit VII likely represents one of their specialized facilities dedicated to specific research, development, or manufacturing activities. These activities typically involve advanced laboratories, pilot plants, and potentially facilities for the production of active pharmaceutical ingredients (APIs), intermediates, or other specialized chemicals on a contract basis. The company is known for its scientific expertise, state-of-the-art infrastructure, and adherence to global quality and regulatory standards. Syngene is not a trading company; it is a service provider that operates extensive physical infrastructure for scientific research and manufacturing.

SYNGENE INTERNATIONAL LTD UNIT VII, as part of Syngene International Ltd, operates as a leading contract research, development, and manufacturing organization (CRDMO). The company primarily provides a comprehensive range of scientific services and manufactures various intermediate compounds and active pharmaceutical ingredients on behalf of its global clients rather than selling proprietary end-products directly to consumers.

The products manufactured or services offered by SYNGENE INTERNATIONAL LTD UNIT VII for its clients include:

Discovery Research Services: This encompasses target identification and validation, hit identification and lead optimization, in vitro and in vivo pharmacology studies, and ADME and PK (absorption, distribution, metabolism, excretion, and pharmacokinetics) studies.

Development Services: These services cover preclinical and clinical development support, formulation development, analytical method development and validation, and bioanalytical services for drug candidates.

Manufacturing Services: This involves Good Manufacturing Practice (GMP) compliant manufacturing of Active Pharmaceutical Ingredients (APIs), intermediate chemical manufacturing, and drug product manufacturing for clinical trials and commercial supply. This also extends to biologics manufacturing, including cell line development, process development, analytical development, and GMP manufacturing of biologics.

Integrated Drug Discovery and Development Programs: Providing end-to-end solutions from early-stage discovery to late-stage development and manufacturing across various therapeutic areas.

These services and manufactured materials are supplied to pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies worldwide.